MENU
+Compare
GRRMF
Stock ticker: OTC
AS OF
Jun 25 closing price
Price
$53.55
Change
+$3.09 (+6.12%)
Capitalization
4.1B

GRRMF Gerresheimer AG Forecast, Technical & Fundamental Analysis

Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech... Show more

GRRMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GRRMF with price predictions
Jun 30, 2025

Momentum Indicator for GRRMF turns negative, indicating new downward trend

GRRMF saw its Momentum Indicator move below the 0 level on June 17, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator turned negative. In of the 35 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for GRRMF turned negative on June 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 27 similar instances when the indicator turned negative. In of the 27 cases the stock turned lower in the days that followed. This puts the odds of success at .

GRRMF moved below its 50-day moving average on June 17, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GRRMF crossed bearishly below the 50-day moving average on June 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Aroon Indicator entered an Uptrend today. In of 112 cases where GRRMF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.606) is normal, around the industry mean (24.463). P/E Ratio (32.468) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.011) settles around the average of (0.018) among similar stocks. P/S Ratio (1.775) is also within normal values, averaging (43.062).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GRRMF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GRRMF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
GRRMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

GRRMF paid dividends on June 14, 2021

Gerresheimer AG GRRMF Stock Dividends
А dividend of $1.25 per share was paid with a record date of June 14, 2021, and an ex-dividend date of June 10, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Klaus-Bungert-Strasse 4
Phone
+49 211618100
Employees
11062
Web
https://www.gerresheimer.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FSTA51.150.20
+0.39%
Fidelity MSCI Consumer Staples ETF
GSIG47.580.06
+0.13%
Goldman Sachs Acs Inv Gd Cp 1-5Yr Bd ETF
PQJL26.63N/A
N/A
PGIM NASDAQ-100 BUFFER 12 ETF - JULY
OMFS40.09-0.08
-0.19%
Invesco Russell 2000® Dynamic Mltfct ETF
SBIO30.07-0.28
-0.92%
ALPS Medical Breakthroughs ETF

GRRMF and Stocks

Correlation & Price change

A.I.dvisor tells us that GRRMF and SAFLF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRRMF and SAFLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRRMF
1D Price
Change %
GRRMF100%
N/A
SAFLF - GRRMF
24%
Poorly correlated
N/A
CYDX - GRRMF
23%
Poorly correlated
N/A
IDTA - GRRMF
7%
Poorly correlated
N/A
GNNDY - GRRMF
5%
Poorly correlated
+0.74%
GTHP - GRRMF
3%
Poorly correlated
-10.71%
More